You can buy or sell MCRB and other stocks, options, ETFs, and crypto commission-free!
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. Read More The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected Apr 30, Pre-Market